Exact Sciences Corporation EXAS
104.91 USD 0.00 (+0.00%)
Mar 23, 2026, 9:30 AM EDT
104.91 Day range 104.91
52-week range unavailable
- YTD
- +3.30%
- 1 year
- +129.96%
Analyst view
Price target (mean) —
Ratings (0m) 12 1 buy · 11 hold · 0 sell
- Strong buy1
- Buy0
- Hold11
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 22
- 2 months ago 22
- 3 months ago 22
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.05 | 0.05 – 0.05 | -0.35804 | +114.0% | 842.09M | +19.1% | 1 |
| Next quarter | 0.28 | 0.28 – 0.28 | 0.0999 | +180.3% | 916.73M | +13.0% | 1 |
| Current year | 0.91 | 0.91 – 0.91 | 0.07 | +1200.0% | 3.66B | +12.7% | 1 |
| Next year | 1.90 | 1.90 – 1.90 | 0.91 | +108.8% | 4.11B | +12.3% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 20, 2026 | Mizuho | Downgrade | Outperform | Neutral |
| Jan 5, 2026 | Evercore ISI Group | Downgrade | Outperform | In-Line |
| Nov 28, 2025 | Stifel | Downgrade | Buy | Hold |
| Nov 25, 2025 | Canaccord Genuity | Downgrade | Buy | Hold |
| Nov 24, 2025 | Benchmark | Downgrade | Buy | Hold |
| Nov 24, 2025 | Jefferies | Downgrade | Buy | Hold |
| Nov 21, 2025 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Nov 21, 2025 | William Blair | Downgrade | Outperform | Market Perform |
| Nov 21, 2025 | Guggenheim | Downgrade | Buy | Neutral |
| Nov 21, 2025 | Barclays | Downgrade | Overweight | Equal-Weight |
| Nov 20, 2025 | BTIG | Downgrade | Buy | Neutral |
| Nov 11, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Nov 5, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 4, 2025 | TD Cowen | Maintained | Buy | Buy |
| Nov 4, 2025 | Baird | Maintained | Outperform | Outperform |
| Nov 4, 2025 | Benchmark | Maintained | Buy | Buy |
| Nov 4, 2025 | Guggenheim | Maintained | Buy | Buy |
| Nov 4, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 4, 2025 | Stifel | Maintained | Buy | Buy |
| Nov 4, 2025 | BTIG | Maintained | Buy | Buy |
| Oct 22, 2025 | BTIG | Maintained | Buy | Buy |
| Oct 8, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 7, 2025 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Oct 2, 2025 | Barclays | Maintained | Overweight | Overweight |
| Sep 11, 2025 | Craig-Hallum | Maintained | Buy | Buy |
| Aug 12, 2025 | BTIG | Maintained | Buy | Buy |
| Aug 11, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 8, 2025 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 7, 2025 | UBS | Maintained | Neutral | Neutral |
| Aug 7, 2025 | RBC Capital | Maintained | Sector Perform | Sector Perform |
